490 related articles for article (PubMed ID: 33932468)
1. Single-cell transcriptomics applied to emigrating cells from psoriasis elucidate pathogenic versus regulatory immune cell subsets.
Kim J; Lee J; Kim HJ; Kameyama N; Nazarian R; Der E; Cohen S; Guttman-Yassky E; Putterman C; Krueger JG
J Allergy Clin Immunol; 2021 Nov; 148(5):1281-1292. PubMed ID: 33932468
[TBL] [Abstract][Full Text] [Related]
2. Tissue-Resident Memory CD8+ T Cells From Skin Differentiate Psoriatic Arthritis From Psoriasis.
Leijten EF; van Kempen TS; Olde Nordkamp MA; Pouw JN; Kleinrensink NJ; Vincken NL; Mertens J; Balak DMW; Verhagen FH; Hartgring SA; Lubberts E; Tekstra J; Pandit A; Radstake TR; Boes M
Arthritis Rheumatol; 2021 Jul; 73(7):1220-1232. PubMed ID: 33452865
[TBL] [Abstract][Full Text] [Related]
3. CCR10 regulates balanced maintenance and function of resident regulatory and effector T cells to promote immune homeostasis in the skin.
Xia M; Hu S; Fu Y; Jin W; Yi Q; Matsui Y; Yang J; McDowell MA; Sarkar S; Kalia V; Xiong N
J Allergy Clin Immunol; 2014 Sep; 134(3):634-644.e10. PubMed ID: 24767879
[TBL] [Abstract][Full Text] [Related]
4. Single-cell transcriptomics suggest distinct upstream drivers of IL-17A/F in hidradenitis versus psoriasis.
Kim J; Lee J; Li X; Lee HS; Kim K; Chaparala V; Murphy W; Zhou W; Cao J; Lowes MA; Krueger JG
J Allergy Clin Immunol; 2023 Sep; 152(3):656-666. PubMed ID: 37271319
[TBL] [Abstract][Full Text] [Related]
5. Multi-omics segregate different transcriptomic impacts of anti-IL-17A blockade on type 17 T-cells and regulatory immune cells in psoriasis skin.
Kim J; Lee J; Li X; Kunjravia N; Rambhia D; Cueto I; Kim K; Chaparala V; Ko Y; Garcet S; Zhou W; Cao J; Krueger JG
Front Immunol; 2023; 14():1250504. PubMed ID: 37781383
[TBL] [Abstract][Full Text] [Related]
6. Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets.
Fujita H; Shemer A; Suárez-Fariñas M; Johnson-Huang LM; Tintle S; Cardinale I; Fuentes-Duculan J; Novitskaya I; Carucci JA; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2011 Sep; 128(3):574-82.e1-12. PubMed ID: 21704361
[TBL] [Abstract][Full Text] [Related]
7. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis.
Lovato P; Norsgaard H; Tokura Y; Røpke MA
J Dermatol Sci; 2016 Mar; 81(3):153-64. PubMed ID: 26794805
[TBL] [Abstract][Full Text] [Related]
8. The imbalance between Type 17 T-cells and regulatory immune cell subsets in psoriasis vulgaris.
Kim J; Moreno A; Krueger JG
Front Immunol; 2022; 13():1005115. PubMed ID: 36110854
[TBL] [Abstract][Full Text] [Related]
9. Psoriasis-associated impairment of CCL27/CCR10-derived regulation leads to IL-17A/IL-22-producing skin T-cell overactivation.
Li C; Xu M; Coyne J; Wang WB; Davila ML; Wang Y; Xiong N
J Allergy Clin Immunol; 2021 Feb; 147(2):759-763.e9. PubMed ID: 32533971
[TBL] [Abstract][Full Text] [Related]
10. Myeloid but not plasmacytoid blood DCs possess Th1 polarizing and Th1/Th17 recruiting capacity in psoriasis.
Khasawneh A; Baráth S; Medgyesi B; Béke G; Dajnoki Z; Gáspár K; Jenei A; Pogácsás L; Pázmándi K; Gaál J; Bácsi A; Szegedi A; Kapitány A
Immunol Lett; 2017 Sep; 189():109-113. PubMed ID: 28414181
[TBL] [Abstract][Full Text] [Related]
11. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
12. Controlling the pro-inflammatory function of 6-sulfo LacNAc (slan) dendritic cells with dimethylfumarate.
Oehrl S; Olaru F; Kunze A; Maas M; Pezer S; Schmitz M; Schäkel K
J Dermatol Sci; 2017 Sep; 87(3):278-284. PubMed ID: 28732748
[TBL] [Abstract][Full Text] [Related]
13. Streptococcus pyogenes-induced cutaneous lymphocyte antigen-positive T cell-dependent epidermal cell activation triggers TH17 responses in patients with guttate psoriasis.
Ruiz-Romeu E; Ferran M; Sagristà M; Gómez J; Giménez-Arnau A; Herszenyi K; Hóllo P; Celada A; Pujol R; Santamaria-Babí LF
J Allergy Clin Immunol; 2016 Aug; 138(2):491-499.e6. PubMed ID: 27056267
[TBL] [Abstract][Full Text] [Related]
14. GILZ regulates Th17 responses and restrains IL-17-mediated skin inflammation.
Jones SA; Perera DN; Fan H; Russ BE; Harris J; Morand EF
J Autoimmun; 2015 Jul; 61():73-80. PubMed ID: 26077873
[TBL] [Abstract][Full Text] [Related]
15. Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC).
Homey B; Wang W; Soto H; Buchanan ME; Wiesenborn A; Catron D; Müller A; McClanahan TK; Dieu-Nosjean MC; Orozco R; Ruzicka T; Lehmann P; Oldham E; Zlotnik A
J Immunol; 2000 Apr; 164(7):3465-70. PubMed ID: 10725697
[TBL] [Abstract][Full Text] [Related]
16. Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells.
Zaba LC; Fuentes-Duculan J; Eungdamrong NJ; Abello MV; Novitskaya I; Pierson KC; Gonzalez J; Krueger JG; Lowes MA
J Invest Dermatol; 2009 Jan; 129(1):79-88. PubMed ID: 18633443
[TBL] [Abstract][Full Text] [Related]
17. The role of Th17/Tc17 peripheral blood T cells in psoriasis and their positive therapeutic response.
Eysteinsdóttir JH; Sigurgeirsson B; Ólafsson JH; Fridriksson T; Agnarsson BA; Davíðsson S; Valdimarsson H; Lúðvíksson BR
Scand J Immunol; 2013 Dec; 78(6):529-37. PubMed ID: 24111693
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis.
Yawalkar N; Tscharner GG; Hunger RE; Hassan AS
J Dermatol Sci; 2009 May; 54(2):99-105. PubMed ID: 19264456
[TBL] [Abstract][Full Text] [Related]
19. Psoriasis and other Th17-mediated skin diseases.
Tokura Y; Mori T; Hino R
J UOEH; 2010 Dec; 32(4):317-28. PubMed ID: 21226422
[TBL] [Abstract][Full Text] [Related]
20. Differential Involvement of Programmed Cell Death Ligands in Skin Immune Responses.
Tanaka R; Ichimura Y; Kubota N; Saito A; Nakamura Y; Ishitsuka Y; Watanabe R; Fujisawa Y; Mizuno S; Takahashi S; Fujimoto M; Okiyama N
J Invest Dermatol; 2022 Jan; 142(1):145-154.e8. PubMed ID: 34310947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
